News

Valencia 2023
Valencia 2023
License contract signed
License contract signed
CureDiab at the 6th Global NASH Congress
CureDiab at the 6th Global NASH Congress
alytas therapeutics collaborates with CureDiab
alytas therapeutics collaborates with CureDiab
New shareholder structure
New shareholder structure
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!

Connect, follow and have a conversation with us

CMR CureDiab Metabolic Research GmbH
+49 172 2045992
contact@curediab.de
Merowingerplatz 1, 40225 Düsseldorf

© 2022 cureDiab All rights reserved

Services